EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES

Aim. To evaluate a short-term efficacy and safety of nebivolol and carvedilol in hypertensive patients of different ages in acute pharmacological test (APT).Material and methods. 119 patients with arterial hypertension (HT) 2-3 degrees aged 33-89 y.o. were involved into the study. Patients were spli...

Full description

Saved in:
Bibliographic Details
Main Authors: O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/716
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227900336734208
author O. V. Fedorishina
A. A. Dzizinsky
K. V. Protasov
V. A. Protasova
T. I. Kucherova
E. G. Zakharova
D. D. Baskhaeva
T. S. Sukhoroslova
O. V. Perkova
author_facet O. V. Fedorishina
A. A. Dzizinsky
K. V. Protasov
V. A. Protasova
T. I. Kucherova
E. G. Zakharova
D. D. Baskhaeva
T. S. Sukhoroslova
O. V. Perkova
author_sort O. V. Fedorishina
collection DOAJ
description Aim. To evaluate a short-term efficacy and safety of nebivolol and carvedilol in hypertensive patients of different ages in acute pharmacological test (APT).Material and methods. 119 patients with arterial hypertension (HT) 2-3 degrees aged 33-89 y.o. were involved into the study. Patients were split into 2 groups according to age: young and middle-aged patients (30-59 y.o.); elderly and senile patients (≥60 y.o.). All patients were randomized for carvedilol (12.5 mg once daily) or nebivolol (5 mg once daily) therapy after wash-out period (3-10 days). Ambulatory blood pressure monitoring (ABPM) was performed one day before and one day after first drug taking and ABPM indices were compared.Results. APT with carvedilol and nebivolol in patients of young and middle age showed significant antihypertensive effect on systolic (-6.9 and -6.0 mm Hg, resp.), diastolic (- 4.6 and -4.7 mm Hg, resp.) and pulse (-1.7 and -1.4 mm Hg, resp.) blood pressure (BP). In patients of elderly and senile age the first daily dose of nebivolol did not have influence on systolic and pulse BP (-2.73 and +0.50 mm Hg, resp., p>0.05), unlike carvedilol (-5.27 and -1.43 mm Hg, resp. p<0.05). Carvedilol and nebivolol increased of hypotension time index for diastolic BP in younger (7,6 and 7,7%, resp.) and elder (11 and 8,2% resp.) patients.Conclusion. Carvedilol in initial dose reduces systolic and pulse BP more significantly than nebivolol does in hypertensive elderly and senile patients. Increase of hypotension time index for diastolic BP revealed for both drugs can limit their use in patients with initially low diastolic BP.
format Article
id doaj-art-d93a78ac7cc74da1bfd9fad3fc277a6d
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2016-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-d93a78ac7cc74da1bfd9fad3fc277a6d2025-08-23T10:00:22ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0155414510.20996/1819-6446-2009-5-5-41-45715EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGESO. V. Fedorishina0A. A. Dzizinsky1K. V. Protasov2V. A. Protasova3T. I. Kucherova4E. G. Zakharova5D. D. Baskhaeva6T. S. Sukhoroslova7O. V. Perkova8Irkutsk State Medical Institute for Postgraduate EducationIrkutsk State Medical Institute for Postgraduate EducationIrkutsk State Medical Institute for Postgraduate EducationAngarsk city hospital №1Angarsk city hospital №1Angarsk city hospital №1Angarsk city hospital №1Angarsk city hospital №1Angarsk city hospital №1Aim. To evaluate a short-term efficacy and safety of nebivolol and carvedilol in hypertensive patients of different ages in acute pharmacological test (APT).Material and methods. 119 patients with arterial hypertension (HT) 2-3 degrees aged 33-89 y.o. were involved into the study. Patients were split into 2 groups according to age: young and middle-aged patients (30-59 y.o.); elderly and senile patients (≥60 y.o.). All patients were randomized for carvedilol (12.5 mg once daily) or nebivolol (5 mg once daily) therapy after wash-out period (3-10 days). Ambulatory blood pressure monitoring (ABPM) was performed one day before and one day after first drug taking and ABPM indices were compared.Results. APT with carvedilol and nebivolol in patients of young and middle age showed significant antihypertensive effect on systolic (-6.9 and -6.0 mm Hg, resp.), diastolic (- 4.6 and -4.7 mm Hg, resp.) and pulse (-1.7 and -1.4 mm Hg, resp.) blood pressure (BP). In patients of elderly and senile age the first daily dose of nebivolol did not have influence on systolic and pulse BP (-2.73 and +0.50 mm Hg, resp., p>0.05), unlike carvedilol (-5.27 and -1.43 mm Hg, resp. p<0.05). Carvedilol and nebivolol increased of hypotension time index for diastolic BP in younger (7,6 and 7,7%, resp.) and elder (11 and 8,2% resp.) patients.Conclusion. Carvedilol in initial dose reduces systolic and pulse BP more significantly than nebivolol does in hypertensive elderly and senile patients. Increase of hypotension time index for diastolic BP revealed for both drugs can limit their use in patients with initially low diastolic BP.https://www.rpcardio.online/jour/article/view/716arterial hypertensioncarvedilolnebivololambulatory blood pressure monitoringacute pharmacological test
spellingShingle O. V. Fedorishina
A. A. Dzizinsky
K. V. Protasov
V. A. Protasova
T. I. Kucherova
E. G. Zakharova
D. D. Baskhaeva
T. S. Sukhoroslova
O. V. Perkova
EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
Рациональная фармакотерапия в кардиологии
arterial hypertension
carvedilol
nebivolol
ambulatory blood pressure monitoring
acute pharmacological test
title EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
title_full EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
title_fullStr EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
title_full_unstemmed EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
title_short EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
title_sort efficacy and safety of vasoactive beta blockers in acute pharmacological test in hypertensive patients of different ages
topic arterial hypertension
carvedilol
nebivolol
ambulatory blood pressure monitoring
acute pharmacological test
url https://www.rpcardio.online/jour/article/view/716
work_keys_str_mv AT ovfedorishina efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages
AT aadzizinsky efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages
AT kvprotasov efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages
AT vaprotasova efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages
AT tikucherova efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages
AT egzakharova efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages
AT ddbaskhaeva efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages
AT tssukhoroslova efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages
AT ovperkova efficacyandsafetyofvasoactivebetablockersinacutepharmacologicaltestinhypertensivepatientsofdifferentages